Cargando…
Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957381/ https://www.ncbi.nlm.nih.gov/pubmed/35351541 http://dx.doi.org/10.1016/j.jinf.2022.03.022 |
_version_ | 1784676752448028672 |
---|---|
author | Yoon, Jin Gu Yoo, Jin Sae Lee, Jungmin Hyun, Hak-Jun Seong, Hye Noh, Ji Yun Cheong, Hee Jin Kim, Woo Joo Kim, Young Rong Heo, Jung Yeon Bae, Joon-Yong Cui, Chunguang Lee, Sohyun Park, Man-Seong Song, Joon Young |
author_facet | Yoon, Jin Gu Yoo, Jin Sae Lee, Jungmin Hyun, Hak-Jun Seong, Hye Noh, Ji Yun Cheong, Hee Jin Kim, Woo Joo Kim, Young Rong Heo, Jung Yeon Bae, Joon-Yong Cui, Chunguang Lee, Sohyun Park, Man-Seong Song, Joon Young |
author_sort | Yoon, Jin Gu |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8957381 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The British Infection Association. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89573812022-03-28 Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment Yoon, Jin Gu Yoo, Jin Sae Lee, Jungmin Hyun, Hak-Jun Seong, Hye Noh, Ji Yun Cheong, Hee Jin Kim, Woo Joo Kim, Young Rong Heo, Jung Yeon Bae, Joon-Yong Cui, Chunguang Lee, Sohyun Park, Man-Seong Song, Joon Young J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-06 2022-03-26 /pmc/articles/PMC8957381/ /pubmed/35351541 http://dx.doi.org/10.1016/j.jinf.2022.03.022 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Yoon, Jin Gu Yoo, Jin Sae Lee, Jungmin Hyun, Hak-Jun Seong, Hye Noh, Ji Yun Cheong, Hee Jin Kim, Woo Joo Kim, Young Rong Heo, Jung Yeon Bae, Joon-Yong Cui, Chunguang Lee, Sohyun Park, Man-Seong Song, Joon Young Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment |
title | Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment |
title_full | Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment |
title_fullStr | Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment |
title_full_unstemmed | Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment |
title_short | Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment |
title_sort | viable sars-cov-2 shedding under remdesivir and dexamethasone treatment |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957381/ https://www.ncbi.nlm.nih.gov/pubmed/35351541 http://dx.doi.org/10.1016/j.jinf.2022.03.022 |
work_keys_str_mv | AT yoonjingu viablesarscov2sheddingunderremdesiviranddexamethasonetreatment AT yoojinsae viablesarscov2sheddingunderremdesiviranddexamethasonetreatment AT leejungmin viablesarscov2sheddingunderremdesiviranddexamethasonetreatment AT hyunhakjun viablesarscov2sheddingunderremdesiviranddexamethasonetreatment AT seonghye viablesarscov2sheddingunderremdesiviranddexamethasonetreatment AT nohjiyun viablesarscov2sheddingunderremdesiviranddexamethasonetreatment AT cheongheejin viablesarscov2sheddingunderremdesiviranddexamethasonetreatment AT kimwoojoo viablesarscov2sheddingunderremdesiviranddexamethasonetreatment AT kimyoungrong viablesarscov2sheddingunderremdesiviranddexamethasonetreatment AT heojungyeon viablesarscov2sheddingunderremdesiviranddexamethasonetreatment AT baejoonyong viablesarscov2sheddingunderremdesiviranddexamethasonetreatment AT cuichunguang viablesarscov2sheddingunderremdesiviranddexamethasonetreatment AT leesohyun viablesarscov2sheddingunderremdesiviranddexamethasonetreatment AT parkmanseong viablesarscov2sheddingunderremdesiviranddexamethasonetreatment AT songjoonyoung viablesarscov2sheddingunderremdesiviranddexamethasonetreatment |